| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 05/01/1996 | CN1121682A Coated meristermatic tissue |
| 05/01/1996 | CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 04/30/1996 | US5512600 Dissolving biocompatible polymer in solvent, adding fibers of first polymer, desolventizing to form matrix of dissolved polymer around fibers of first polymer, melting first polymer, cooling, dissolving second polymer |
| 04/30/1996 | US5512482 Plant thioesterases |
| 04/30/1996 | US5512477 Serum-free medium supplement |
| 04/30/1996 | US5512475 Three-dimensional skin cell and tissue culture system |
| 04/30/1996 | US5512474 Cell culture support containing a cell adhesion factor and a positively-charged molecule |
| 04/30/1996 | US5512460 Glia activating factor and its production |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512453 Activated killer monocytes and tumoricidal activity and pharmaceutical compositions |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/30/1996 | US5512329 Substrate surface preparation |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | WO1996012185A1 Method for screening compositions |
| 04/25/1996 | WO1996012037A1 Method for analysing a cell cluster |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012028A1 Production of peptides in plants as viral coat protein fusions |
| 04/25/1996 | WO1996012025A1 TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996012011A1 Reporter cell line |
| 04/25/1996 | WO1996012009A2 Methods for engineering antigen-presenting cells |
| 04/25/1996 | WO1996011951A2 Keratinocyte growth factor analogs |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011696A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996005286A3 Cell death accelerator and cell death inhibitor |
| 04/25/1996 | WO1996003513A3 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202048A1 Screening assay for anti-hiv drugs |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707641A1 An enzyme with protease activity |
| 04/24/1996 | EP0707634A1 New stromal cell lines from human bone marrow and their use |
| 04/24/1996 | EP0707599A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/24/1996 | EP0707498A1 Implantable prosthesis, kit and device for manufacturing the same |
| 04/24/1996 | EP0679256A4 Method to distinguish hematopoietic progenitor cells. |
| 04/24/1996 | EP0621766A4 -i(in vitro) cornea equivalent model. |
| 04/24/1996 | EP0407390B1 Biocompatible coatings |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121356A Use of tomato E8-derived promoters to express heterologous genes, E.G. 5-adenosylmethionine hydrolase, in ripening fruit |
| 04/24/1996 | CN1121355A Variants of bile salt-stimulated lipase, DNA molecules encoding them, and transgenic non-human mammals |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/23/1996 | US5510628 Using diamine as cell adhesion promoter |
| 04/23/1996 | US5510471 Herbicide tolerance |
| 04/23/1996 | US5510264 Antibodies which bind meningitis related homologous antigenic sequences |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510262 Cell-culturing apparatus and method employing a macroporous support |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510258 Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics |
| 04/23/1996 | US5510257 Hollow fiber immobilization with chopped microporous hollow fibers |
| 04/23/1996 | US5510255 Plant fatty acid synthases |
| 04/23/1996 | US5510254 Three dimensional cell and tissue culture system |
| 04/23/1996 | US5510253 Dna sequences |
| 04/23/1996 | CA1338260C Human protein s, a plasma protein regulator of hemostasis |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996007730A3 Chemical process for promoting the proliferation of animal cells |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/17/1996 | EP0707069A2 Process for preparing virus-resistant transgenic plant |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706570A1 Plants having modified response to ethylene |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706565A1 A synthetic gene for d4 dopamine receptors |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0630403A4 Methods for the regulation of plant fertility. |
| 04/17/1996 | EP0619838A4 Repopulation of testicular seminiferous tubules with foreign cells. |
| 04/17/1996 | EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation |
| 04/17/1996 | EP0598029A4 Retroviral vectors containing internal ribosome entry sites. |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0483194B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |